Diminished viability of human ovarian cancer cells by antigen-specific delivery of carbon monoxide with a family of photoactivatable antibody-photoCORM conjugates
Open Access
- 20 November 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 11 (2) , 467-473
Abstract
Carbon monoxide (CO)-releasing antibody conjugates were synthesized utilizing a photoactivatable CO-releasing molecule (photoCORM) and mouse monoclonal antibodies linked by a biotin-streptavidin system. Different monoclonal antibodies raised against different surface-expressed antigens that are implicated in ovarian cancer afforded a family of antibody-photoCORM conjugates (Ab-photoCORMs). In an immunosorbent/cell viability assay, Ab-photoCORMs accumulated onto ovarian cancer cells expressing the target antigens, delivering cytotoxic doses of CO in vitro. The results described here provide the first example of an “immunoCORM”, a proof-of-the-concept antibody-drug conjugate that delivers a gaseous molecule as a warhead to ovarian cancer.Keywords
Funding Information
- National Science Foundation (DMR-1409335)
- Cancer Research Coordinating Committee (CTR-19-580346)
- National Institutes of Health (HD087221)
This publication has 29 references indexed in Scilit:
- Optical control of insulin release using a photoswitchable sulfonylureaNature Communications, 2014
- Carbon‐Monoxide‐Releasing Molecules for the Delivery of Therapeutic CO In VivoAngewandte Chemie International Edition, 2014
- Novel lead structures and activation mechanisms for CO‐releasing molecules (CORMs)British Journal of Pharmacology, 2014
- Carbon monoxide – physiology, detection and controlled releaseChemical Communications, 2014
- Photopharmacology: Beyond Proof of PrincipleJournal of the American Chemical Society, 2014
- Rapid CO release from a Mn(i) carbonyl complex derived from azopyridine upon exposure to visible light and its phototoxicity toward malignant cellsChemical Communications, 2013
- The therapeutic potential of carbon monoxideNature Reviews Drug Discovery, 2010
- PD/PDT for gynecological disease: A clinical reviewPhotodiagnosis and Photodynamic Therapy, 2005
- Clinical effect of meso‐tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: preliminary resultsBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- The generation of antibody diversityAmerican Journal of Hematology, 1982